Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Revenue (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Revenue for 5 consecutive years, with -$756000.0 as the latest value for Q1 2020.

  • On a quarterly basis, Revenue fell 8500.0% to -$756000.0 in Q1 2020 year-over-year; TTM through Dec 2020 was -$756000.0, a 2200.0% decrease, with the full-year FY2019 number at $36000.0, down 99.8% from a year prior.
  • Revenue was -$756000.0 for Q1 2020 at Forte Biosciences, down from $9000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $18.0 million in Q3 2018 to a low of -$1.0 million in Q4 2016.
  • A 5-year average of $892562.5 and a median of $9000.0 in 2018 define the central range for Revenue.
  • Peak YoY movement for Revenue: soared 4387.86% in 2018, then tumbled 8500.0% in 2020.
  • Forte Biosciences' Revenue stood at -$1.0 million in 2016, then skyrocketed by 100.98% to $10000.0 in 2017, then decreased by 10.0% to $9000.0 in 2018, then changed by 0.0% to $9000.0 in 2019, then crashed by 8500.0% to -$756000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Revenue are -$756000.0 (Q1 2020), $9000.0 (Q4 2019), and $9000.0 (Q3 2019).